Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Monday, May 27, 2024 for the Memorial Day holiday. Have a healthy, happy holiday.

Hide

Monitor chronic kidney disease with confidence

Chronic kidney disease (CKD) due to diabetes occurs in 20 to 40% of patients and is the most common cause of end-stage renal disease.1

Quest Diagnostics’ Diabetes, Advancing CKD Management Panel provides you with a way to offer comprehensive annual testing to diabetes patients who may be at risk for CKD or who have progressed to stage 3 or 4 CKD.

Learn more about the Diabetes, Advancing CKD Management Panel

Learn more about guideline-based testing for CKD

Nonalcoholic fatty liver disease

The Nonalcoholic Fatty Liver Disease (NAFLD) Score Panel identifies diabetes patients who are at risk for developing serious liver disease. A complete fibrosis score is calculated and provided at no additional cost.

Associated risk tests

This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.


References

  1. CDC. Chronic kidney disease in the United States, 2021. Last reviewed March 4, 2021. Accessed April 2, 2021. https://www.cdc.gov/kidneydisease/publications-resources/2019-national-facts.html